R97 ICD-10-CM Code: Abnormal tumor markers
A clear reference for the official code description, hierarchy, and related coding information from the FY 2027 U.S. release.
Official description
R97Abnormal tumor markers
ICD-10-CM diagnosis code · United States clinical modification
Where R97 sits
- 1
Chapter 18
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)
- 2
Section
Abnormal tumor markers (R97)
- 3
Category R97
Abnormal tumor markers
- 4
Code R97
Abnormal tumor markers
Codes under R97
R97 is a non-billable category. Choose the child code that best matches the documented diagnosis.
Notes for this code
Inclusion terms
- Elevated tumor associated antigens [TAA]
- Elevated tumor specific antigens [TSA]
Code first
No “code first” instruction is listed for R97.
Use additional code
No “use additional code” instruction is listed for R97.
Excludes1
Conditions that should not be reported together with this code.
No Excludes1 note is listed for R97.
Excludes2
Conditions not included here that may be reported separately when present.
No Excludes2 note is listed for R97.
Source and release
- Data release
- U.S. ICD-10-CM · FY 2027
- Effective date
- Oct 1, 2026
- Publisher
- Vero Scribe Inc.
This reference is generated from Vero’s ICD-10-CM description, hierarchy, and code-note dataset. The visible content and structured data share that source.
Frequently asked questions
What does ICD-10-CM code R97 mean?
R97 is the FY 2027 U.S. ICD-10-CM code for “Abnormal tumor markers.”
Is R97 a billable or specific ICD-10-CM code?
No. R97 has more specific child codes in the FY 2027 reference data. Select the code that matches the documentation and confirm the active code set and payer requirements.
Where is R97 located in ICD-10-CM?
R97 is listed in Chapter 18, Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99), within Abnormal tumor markers (R97) (R97–R97), under category R97, Abnormal tumor markers.
What coding notes are listed for R97?
Its listed inclusion terms are Elevated tumor associated antigens [TAA]; Elevated tumor specific antigens [TSA]. No code-first instruction is listed. No Excludes1 note is listed. No Excludes2 note is listed.